Autologous stem cell transplantation following high-dose chemotherapy in children with high-risk neuroblastoma: Practicality in resource-limited countries
Pediatr Blood Cancer
.
2020 May;67(5):e28176.
doi: 10.1002/pbc.28176.
Epub 2020 Jan 21.
Authors
Sie Chong Doris Lau
1
2
,
Mohamed Najib Mohamed Unni
1
,
Kok Hoi Teh
1
,
Mimi Azura Aziz
3
,
Zulaiha Muda
1
,
Shoba Anne Thomas
1
,
Shiao Wei Quah
1
,
Hishamshah Ibrahim
1
,
Ida Shahnaz Othman
1
Affiliations
1
Department of Paediatrics, Hospital Wanita & Kanak-Kanak Kuala Lumpur, Kuala Lumpur, Malaysia.
2
Department of Paediatrics, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
3
Department of Pathology, Hospital Wanita & Kanak-Kanak Kuala Lumpur, Kuala Lumpur, Malaysia.
PMID:
31965709
DOI:
10.1002/pbc.28176
No abstract available
Publication types
Clinical Trial
Letter
MeSH terms
Autografts
Child, Preschool
Disease-Free Survival
Female
Humans
Infant
Male
Melphalan / administration & dosage*
Neuroblastoma / mortality*
Neuroblastoma / therapy*
Stem Cell Transplantation*
Survival Rate
Substances
Melphalan